SEC Tracker
Get the app

Nu-Med Plus NUMD

Nu-Med Plus sets 2026 Annual Meeting for Dec 14

Item 3.03 Changes shareholder rights, Item 5.03 Amends charter or bylaws, Item 5.08 Director nominations

Form
8-K
Filed
Importance
Major
  1. Annual Meeting to be held virtually on Dec 14, 2026
  2. Shareholders of record on Nov 6, 2026, eligible to vote
  3. Deadline for shareholder proposals is Nov 13, 2026

Written from the 8-K on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when Nu-Med Plus files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

The reading, claim by claim

0 of 1 claim matched the filing text.

Not found in the filing text

  • The company reported $0 in revenue and a net income of $19,670 for the quarter ended June 30, 2026, according to its 10-Q filing.

Similar companies

Companies of similar size in SIC 3841 and related industry codes: the same peer list as the financial tables.

  1. STRATA Skin Sciences SSKN public float $4M, Jun 30, 2025
  2. ENDRA Life Sciences NDRA public float $3M, Jun 30, 2025
  3. Catheter Precision VJET public float $4M, Jun 30, 2025
  4. Global Innovative Platforms GIPL public float $3M, Sep 30, 2025
  5. Interpace Biosciences IDXG public float $3M, Jun 30, 2025